Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1

Fig. 6

Sorafenib and DHA act together to suppress xenograft tumor growth. MDA-MB-231 cells were implanted into the flanks of nude mice fed either an n-3 or n-6 enriched diet. The xenograft tumor growth, indicated by tumor volume, in mice that were treated either with the vehicle alone (a) or with Sorafenib (b) are shown (n = 5, means ± SEM, *p < 0.01)

Back to article page